T1	Participants 42 50	herpetic
T2	Participants 106 108	an
T3	Participants 700 964	RESULTS In the vaccine group, we observed a reduction both in the number (p = 0.016) and average duration (p = 0.050) of recurrences, whereas in the control group, no significant change was found comparing a 12-month period before and after inclusion in the study.
T4	Participants 1209 1212	use
